Innovative and patented MMCR technology
For a controlled release syrup
For a controlled release syrup
The revolutionary MMCR technology (Multi-layer Micro-particle Controlled Release) enables the development of a controlled (sustained or delayed) release syrup.
This technology allows:
Compliance improvement in patients with swallowing impairments (e.g., elderly or paediatric or critically ill individuals).
Increased treatment efficiency for patients that use alternative systems to enable swallowing (e.g., grinding or dissolving).
MMCR technology is applicable to any active ingredient whose daily dose is less than 50 mg. POC (proof of concept) has, to date, been obtained for the 2 possible applications: sustained release (Pramipexole) and delayed release (Esomeprazole).
We are seeking partners for the next steps in development of these molecules or others requiring delayed or sustained release.
This web site uses cookies so that we may provide you with the best user experience possible. The information in the cookies is stored in your browser. They are notably used to recognise you when you return to our site and help our team to understand which sections of the web site you find the most interesting and useful.
This web site uses cookies – small text files that are placed on your machine in order to help the site to provide a better user experience. In general, the cookies are used to record the User’s preferences, store information for things such as shopping baskets and supply anonymised tracking data to third party applications such as Google Analytics. As a general rule, the cookies will provide a better browsing experience. However, you may deactivate the cookies in your web browser. We suggest that you consult the Help menu in your browser.